The PrEP medication used to prevent HIV infections prove to be 100% effective in preventing the disease.
The new study suggests that all participants at high risk of HIV were able to prevent infection during the trial period of 2.5 years.
New studies show an 86 percent risk reduction among high-risk gay men.
